FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine. Disclosed are: use of botulinum toxin for treating paratonia in an elderly patient with cognitive impairment as a result of Alzheimer's disease or dementia and a corresponding method of treating paratonia in these groups of patients.
EFFECT: technical result consists in postponement and prevention of contractures, discomfort and effects of immobility in the elderly patient with cognitive impairment as a result of Alzheimer's disease or dementia.
20 cl, 3 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR RELIEVING SPASTIC SYNDROME ACCOMPANYING INFANTILE CEREBRAL PARALYSIS | 2013 |
|
RU2531468C1 |
| MEMANTINE THERAPY FOR ALZHEIMER'S DISEASE OF LOW AND LOW TO MODERATE SEVERITY | 2005 |
|
RU2371173C2 |
| TREATMENT OF SPASTICITY OF THE LOWER EXTREMITIES | 2018 |
|
RU2788039C2 |
| METHOD FOR COMPLEX REHABILITATION OF PATIENTS IN EARLY REHABILITATION PERIOD OF CEREBRAL APOPLEXY | 2012 |
|
RU2513418C1 |
| METHOD FOR TREATMENT OF HAND SPASTICITY IN PATIENTS WITH CHRONIC IMPAIRMENT OF CONSCIOUSNESS | 2020 |
|
RU2755579C1 |
| METHOD FOR RESTORING MOBILITY OF PATIENTS WITH HEMIPARESIS | 2022 |
|
RU2783354C1 |
| IMPROVED USE OF BOTULINUM NEUROTOXIN IN THE TREATMENT OF SIALORRHEA | 2018 |
|
RU2778481C2 |
| BOTULINUM TOXIN CONTAINING COMPOSITION | 2017 |
|
RU2743746C2 |
| METHOD OF COMPLEX REHABILITATION OF PATIENTS WITH CENTRAL SPASTIC PARESIS OF UPPER EXTREMITIES | 2009 |
|
RU2422167C2 |
| A METHOD FOR ASSESSING THE LONG-TERM EFFECTIVENESS OF USING A HARDWARE-SOFTWARE COMPLEX FOR THE REHABILITATION OF CHILDREN WITH CEREBRAL PALSY | 2020 |
|
RU2744150C1 |
